Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
CEDAR.Co.,Ltd. operates a network of healthcare facilities across Japan, focusing on elder care and rehabilitation services. The company differentiates itself through its proprietary care management technology and strong brand reputation in the region, which drives patient retention and operational efficiency.
CEDAR generates revenue primarily through its elder care facilities, which charge per diem rates for residents. The company benefits from a growing aging population in Japan, allowing it to maintain pricing power. Its competitive advantages include a strong brand, proprietary care management technology, and established relationships with local health authorities.
Changes in government healthcare funding affecting reimbursement rates
Occupancy rates in facilities, particularly in urban areas
Technological advancements in care management impacting operational efficiency
Demographic trends related to Japan's aging population
Regulatory changes in healthcare funding and reimbursement policies
Technological disruption from new care delivery models
Emergence of new entrants in the elder care market with innovative service models
Price competition from established players in the region
High debt levels could lead to liquidity issues if cash flows decline
Potential pension obligations related to employee benefits
moderate - The healthcare sector is somewhat insulated from economic downturns, but funding changes can impact revenue.
Higher interest rates could increase CEDAR's financing costs, given its high debt-to-equity ratio of 7.04, potentially affecting profitability and expansion plans.
high - The company's significant debt levels make it sensitive to credit market conditions, impacting its ability to finance operations and expansion.
value - The stock's low price-to-sales ratio of 0.1x indicates potential undervaluation, appealing to value investors.
moderate - The stock has shown a historical volatility consistent with the healthcare sector, but recent performance has been more stable.
